NASDAQ:MBOT

Microbot Medical - MBOT Stock Forecast, Price & News

$5.16

+0.32 (+6.61%)

(As of 10/4/2022 12:00 AM ET)

Add

Compare

Today's Range: $4.85
▼
$5.26
50-Day Range: $4.58
▼
$5.93
52-Week Range: $4.31
▼
$9.60

Volume: 11,592 shs
Average Volume: 58,864 shs
Market Capitalization: $36.68 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Microbot Medical MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
1.56% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.88
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.97) to ($1.71) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.22 out of 5 stars

Medical Sector

1067th out of 1,087 stocks

Biological Products, Except Diagnostic Industry

168th out of 169 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Microbot Medical.

2.0

Short Interest

Percentage of Shares Shorted
1.56% of the float of Microbot Medical has been sold short.
Short Interest Ratio / Days to Cover
Microbot Medical has a short interest ratio ("days to cover") of 9.7.
Change versus previous month
Short interest in Microbot Medical has recently increased by 2.53%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Microbot Medical does not currently pay a dividend.
Dividend Growth
Microbot Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MBOT.

3.3

News and Social Media Coverage

News Sentiment
Microbot Medical has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Microbot Medical this week, compared to 0 articles on an average week.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Microbot Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
13.55% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 9.90% of the stock of Microbot Medical is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Microbot Medical are expected to grow in the coming year, from ($1.97) to ($1.71) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Microbot Medical is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Microbot Medical is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Microbot Medical has a P/B Ratio of 2.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Microbot Medical (NASDAQ:MBOT) Stock

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

MBOT Stock News Headlines

October 4, 2022 | finance.yahoo.com

Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment

September 19, 2022 | finance.yahoo.com

Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi

September 15, 2022 | finance.yahoo.com

Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal

September 13, 2022 | finance.yahoo.com

Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference

September 12, 2022 | finance.yahoo.com

Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System

September 8, 2022 | finance.yahoo.com

Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke

September 6, 2022 | finance.yahoo.com

Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System

September 2, 2022 | finance.yahoo.com

Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month

August 18, 2022 | finance.yahoo.com

Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons

May 25, 2022 | finance.yahoo.com

11 Best Robotics Stocks Under $10

April 11, 2022 | apnews.com

Microbot Medical to Review Recent Progress During Needham’s Virtual Healthcare Conference

April 6, 2022 | benzinga.com

Microbot Medical Promotes Rachel Vaknin To Chief Financial Officer

April 6, 2022 | seekingalpha.com

Microbot Medical promotes Rachel Vaknin to CFO

April 6, 2022 | finance.yahoo.com

Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer

March 31, 2022 | finance.yahoo.com

Microbot Medical Achieves Significant Regulatory Milestone for the LIBERTY® Robotic System; Files FDA Pre-Submission Package for Regulatory Pathway

March 15, 2022 | nasdaq.com

Pre-market Movers: IXHL, COUP, MGLD, AGRI, EVLV…

February 1, 2022 | finance.yahoo.com

Short Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to Pop

December 28, 2021 | msn.com

Why Microbot Medical Shares Are Sliding Today

December 28, 2021 | finance.yahoo.com

Company News for Dec 28, 2021

December 27, 2021 | finance.yahoo.com

Microbot Medical Surges On Stryker Collaboration

December 27, 2021 | markets.businessinsider.com

Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher

December 27, 2021 | nasdaq.com

Microbot Enters Collaboration Agreement With Stryker - Quick Facts

December 27, 2021 | msn.com

Why Microbot Medical Shares Are Soaring Today

December 27, 2021 | marketwatch.com

Microbot Medical Shares Soar on Collaboration With Stryker >MBOT

December 27, 2021 | finance.yahoo.com

Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

MBOT Company Calendar

Last Earnings: 8/15/2022
Today: 10/04/2022
Next Earnings (Estimated): 11/21/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MBOT
CUSIP: N/A
CIK: 883975
Web: www.microbotmedical.com
Phone: (781) 875-3605
Fax: 781-556-5347
Employees: 14
Year Founded: 2010

Profitability

EPS (Most Recent Fiscal Year): ($1.84)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,310,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -100.10%
Return on Assets: -86.44%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.60
Quick Ratio: 5.60

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.02 per share
Price / Book: 2.55

Miscellaneous

Outstanding Shares: 7,108,000
Free Float: 6,145,000
Market Cap: $36.68 million
Optionable: Not Optionable
Beta: 3.38

Social Links

Key Executives

Mr. Harel Gadot (Age 49)
Co-Founder, Pres, CEO & Chairman
Comp: $813.8k

Mr. Yoseph Bornstein (Age 63)
CO-Founder & Independent Director
Comp: $52.5k

Dr. Simon Sharon MBA (Age 62)
MSc, CTO & GM
Comp: $501.87k

Dr. Eyal Morag M.D. (Age 57)
Chief Medical Officer & Member of Scientific Advisory Board
Comp: $567.06k

Prof. Moshe Shoham D.Sc. (Age 70)
Co-Founder, Scientific Director & Chairman of Scientific Advisory Board

Ms. Rachel Vaknin (Age 43)
Chief Financial Officer

Key Competitors

View All Competitors

Insiders & Institutions

Renaissance Technologies LLC
Bought 4,400 shares on 8/13/2022
Ownership: 0.283%

View All Insider Transactions
View All Institutional Transactions

MBOT Stock - Frequently Asked Questions

How have MBOT shares performed in 2022?: Microbot Medical's stock was trading at $7.50 on January 1st, 2022. Since then, MBOT stock has decreased by 35.5% and is now trading at $4.84.
View the best growth stocks for 2022 here.
When is Microbot Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our MBOT earnings forecast.
How were Microbot Medical's earnings last quarter?: Microbot Medical Inc. (NASDAQ:MBOT) issued its quarterly earnings data on Monday, August, 15th. The biotechnology company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.04.
When did Microbot Medical's stock split?: Microbot Medical shares reverse split on the morning of Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Microbot Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).
What is Microbot Medical's stock symbol?: Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."
How do I buy shares of Microbot Medical?: Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Microbot Medical's stock price today?: One share of MBOT stock can currently be purchased for approximately $4.84.
How much money does Microbot Medical make?: Microbot Medical (NASDAQ:MBOT) has a market capitalization of $34.41 million. The biotechnology company earns $-11,310,000.00 in net income (profit) each year or ($1.84) on an earnings per share basis.
How can I contact Microbot Medical?: Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The official website for the company is www.microbotmedical.com. The biotechnology company can be reached via phone at (781) 875-3605, via email at mpolyviou@evcgroup.com, or via fax at 781-556-5347.

This page (NASDAQ:MBOT) was last updated on 10/4/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Microbot Medical - MBOT Stock Forecast, Price & News

Microbot Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month